Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
UNC Lineberger Comprehensive Cancer Center · with Agency for Healthcare Research and Quality (AHRQ) · NCT07463833
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 207
- US sites recruiting
- 1
- Study start
- June 22, 2026
- Record last updated
- June 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care.
The system highlights summaries showing how different providers may vary in their treatment planning (provider-variability summaries) and points out the best signals or warning signs to look for (optimal cues). By drawing attention to these patterns and cues, the tool aims to help reviewers spot possible treatment-planning mistakes earlier, reduce the chance of errors, and improve overall patient safety.
Being studied: The Artificial Intelligence (AI)/ Machine Learning (ML) contribution to treatment planning
Conditions: Cancer; Prostate Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Inclusion Criteria
Providers only
- ≥18 years
- Peer-review attendees at participating clinics
Patients only
- ≥18 years
- All patients with prostate cancer radiation therapy cases treated at participating sites (no intervention delivered to patients)
Exclusion Criteria
Providers only
- Providers unwilling/unable to comply with study procedures; sites unable to implement the workflow or provide required outcomes.
Patients and Providers
- Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent
Recruiting US locations
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, NC 27599
Site contact: Olivia Morton · 984-974-8441 · olivia_roberts@med.unc.edu
Study contacts (from the official record)
- Olivia Morton · (984) 974-8441 · olivia_roberts@med.unc.edu
- Victoria Xu · (984) 974-8444 · victoria_xu@med.unc.edu
Similar studies in North Carolina
All healthy volunteers studies in North Carolina →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Nalmefene Implant in Healthy Subjects
ReacX Pharmaceuticals, Inc.
- Location
- Morrisville, NC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
University of North Carolina, Chapel Hill
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Breastfeeding Intervention to Prevent Obesity Among Children
University of North Carolina, Greensboro
- Location
- Greensboro, NC + 1 other US site
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Charlotte, NC + 7 other US sites
- Eligibility basics
- Ages 12–55